Helius Medical Technologies, Inc. (HSDT)
NASDAQ: HSDT · IEX Real-Time Price · USD
1.410
-0.050 (-3.42%)
May 31, 2024, 4:00 PM EDT - Market closed
HSDT Revenue
Helius Medical Technologies had revenue of $668.00K in the twelve months ending March 31, 2024, down -5.65% year-over-year. Revenue in the quarter ending March 31, 2024 was $135.00K with 21.62% year-over-year growth. In the year 2023, Helius Medical Technologies had annual revenue of $644.00K, a decrease of -18.17%.
Revenue (ttm)
$668.00K
Revenue Growth
-5.65%
P/S Ratio
5.34
Revenue / Employee
$30,364
Employees
22
Market Cap
3.57M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 644.00K | -143.00K | -18.17% |
Dec 31, 2022 | 787.00K | 265.00K | 50.77% |
Dec 31, 2021 | 522.00K | -139.00K | -21.03% |
Dec 31, 2020 | 661.00K | -835.00K | -55.82% |
Dec 31, 2019 | 1.50M | 1.02M | 212.97% |
Dec 31, 2018 | 478.00K | - | - |
Dec 31, 2017 | 0 | - | - |
Mar 31, 2016 | 0 | - | - |
Mar 31, 2015 | 0 | - | - |
Mar 31, 2014 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Leafly Holdings | 40.05M |
Scorpius Holdings | 9.74M |
Avinger | 7.62M |
Evoke Pharma | 6.11M |
Aditxt | 506.44K |
Catheter Precision | 439.00K |
Assure Holdings | 255.00K |
HSDT News
- 2 days ago - Helius Medical Technologies, Inc. to Present at the Spring MicroCap Rodeo Conference - Accesswire
- 10 days ago - Helius Medical Technologies to Exhibit at 2024 CMSC Annual Meeting, Marking a Year of Achievements: Making PoNS More Available to People with MS - GlobeNewsWire
- 13 days ago - Helius Medical Technologies, Inc. Announces PoNS® Is Now Available on the Veterans Affairs (VA) Federal Supply Schedule (FSS) and General Services Administration (GSA) Advantage Contracts - GlobeNewsWire
- 20 days ago - Helius Medical Technologies, Inc. Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 23 days ago - Helius Medical Technologies, Inc. to Release First Quarter 2024 Financial Results on May 13, 2024 - GlobeNewsWire
- 26 days ago - Helius Medical Technologies, Inc. Announces Pricing of $6.4 Million Public Offering - GlobeNewsWire
- 5 weeks ago - Helius Medical Technologies, Inc. Expands Stroke Clinical Program with Participation of Shepherd Center - GlobeNewsWire
- 2 months ago - Helius Medical stock rallies 40%: explore why - Invezz